Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$4.07 USD
+0.08 (2.01%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.20 +0.13 (3.19%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | 19.23% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -1.05 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.11M | 0.12M | 0.49M | 0.20M |
# of Estimates | 2 | 2 | 2 | 1 |
High Estimate | 0.17M | 0.19M | 0.77M | 0.20M |
Low Estimate | 0.05M | 0.05M | 0.20M | 0.20M |
Year ago Sales | 0.08M | 0.11M | 0.49M | 0.49M |
Year over Year Growth Est. | 37.50% | 9.09% | -0.61% | -58.76% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.25 | -0.98 | -1.05 |
# of Estimates | 4 | 3 | 4 | 3 |
Most Recent Consensus | -0.23 | -0.24 | -0.99 | NA |
High Estimate | -0.23 | -0.24 | -0.80 | -0.80 |
Low Estimate | -0.27 | -0.26 | -1.06 | -1.19 |
Year ago EPS | -0.25 | -0.25 | -0.93 | -0.98 |
Year over Year Growth Est. | 0.00% | 0.00% | -5.38% | -7.99% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.25 | -0.98 | -1.05 |
7 Days Ago | -0.25 | -0.25 | -0.98 | -1.05 |
30 Days Ago | -0.25 | -0.25 | -0.98 | -1.05 |
60 Days Ago | -0.29 | -0.32 | -1.20 | -1.78 |
90 Days Ago | -0.29 | -0.32 | -1.20 | -1.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.25 | -0.98 | -1.05 |
Zacks Consensus Estimate | -0.25 | -0.25 | -0.98 | -1.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.22 | -0.25 | -0.25 | NA |
Estimate | -0.26 | -0.29 | -0.27 | -0.23 | NA |
Difference | 0.05 | 0.07 | 0.02 | -0.02 | 0.03 |
Surprise | 19.23% | 24.14% | 7.41% | -8.70% | 10.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more